Survey on toxoplasma infection in first episode of schizophrenia and its influence on patients' psychiatric symptoms
Wang Hui-ling,Wang Gao-hua,Li Qiu-ying,Chang Shu,Wu Jian-hong
2005-01-01
Abstract:BACKGROUND: It is hypothesized that Toxoplasma Gondii (T. gondii) may contribute to the development of partial schizophrenia at least, as is supported by several clinical and laboratory researches.OBJECTIVE: To survey the prevalence of antibodies to T. gondii in patients with first episode of schizophrenia and their mothers and explore the difference in clinical symptoms between seropositive and seronegative schizophrenic patients. DESIGN: A grouped case-control observationSETTING: Department of Psychiatry, Renmin Hospital, Wuhan University.PARTICIPANTS: The schizophrenic group included 600 cases of schizophrenia of first episode, who were hospitalized at the Psychiatry Department, Renmin Hospital, Wuhan University from January 2000 to December 2004. The patient's relatives agreed to participate in the investigation. The normal controls included 200 healthy people who came to the hospital to receive health examination and did not have any physical or mental disorders. And 200 inpatients with physical diseases and without mental disorders in the same hospital were chosen to form a physical disease control group. Totally 252 serum samples were collected from the mothers of the schizophrenic patients.METHODS: ① The level of IgG and IgM antibody of T.gondii were tested with ELISA. ②The patients received 30-40 minutes of semi-structured interview after they were admitted to the hospital for 2 or 3 days. Data required for scoring were obtained from the medical team of the inpatients and their families. The patients' information about family history, course of disease, education, age of onset, age of their mothers and living areas were recorded. ③The psychiatric symptoms of the patients with schizophrenia were scored with the Positive and Negative Syndrome Scale (PANSS). It included seven items of the positive subscale (delusions, conceptual disorganization, hallucinatory behavior, excitement, grandiosity, suspiciousness/ persecution, and hostility); seven items of the negative subscale (blunted affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of conversation, and stereotyped thinking); sixteen items of the general psychopathology subscale (somatic concern, anxiety, guilt, tension, mannerisms and posturing, depression, motor retardation, uncooperativeness, unusual thought content, disorientation, poor attention, lack of judgment and insight, disturbance of volition, poor impulse control, preoccupation, and active social avoidance); and three complementary items (anger, difficulty in delaying gratification, affective lability) to assess the risk of attack. Seven-grade scores were used, with 1 representing none and 7 representing very severe in the severity of symptoms. The evaluation was carried out in the ward on the admitted day of the patients . ④Independent t-test was used for continuous numerical variables, and chi-squared test was used for qualitative data.MAIN OUTCOME MEASURES: ① The rates of seropositivity to antibody to T. gondii in the normal control group, the physical disease control group, the schizophrenic group and the mother group were compared. ②The age, educational years, disease of course, age of onset, age of the mothers in the seropositive and seronegative schizophrenic patients were compared.③The rate of positive family history of mental disorders, proportion of living areas, the rates of seropositivity to T.gondii in the mothers between the seropositive patients with schizophrenia and the seronegative patients with schizophrenia were compared. ④The scores of PANSS of the seropositive and the seronegative schizophrenic patients..RESULTS: The data of the 600 patients with schizophrenia, 200 normal controls, 200 physical disease controls, 252 mothers of the schizophrenic patients (206 mothers of seronegative schizophrenic patients and 46 mothers of seropositive schizophrenic patients) were analyzed. ① The rate of positive IgG, IgM, IgG or IgM antibody among the normal controls, the physical disease controls, the schizophrenia and the mothers of the patients were different statistically (P < 0.01). ②Further chi-squared tests indicated that there was no statistical difference for IgG, IgM, IgG or IgM seropositive rate between the normal control group and the physical disease patient. ③The IgG seropositive rate in the mothers of the schizophrenic patients was higher than that in the schizophrenic group and the merged control group (the normal control group plus the physical disease patient group) (P < 0.05, 0.01); and the same rate in the schizophrenic group was higher than that in the merged control group (P < 0.01). ④The IgM seropositive rate in the mothers of the schizophrenic patients was higher than that in the schizophrenic group and the merged control group (the normal control group plus the physical disease patient) (P < 0.05, 0.01); and the same rate in the schizophrenic group was higher than that in the merged control group (P < 0.05).⑤ The IgG or IgM seropositive rate in the mothers of the schizophrenic patients was higher than that in the schizophrenic group and the merged control group (the normal control group plus the physical disease patient) (both P < 0.01); and the same rate in the schizophrenic group was higher than that in the merged control group (P < 0.01). ⑥The schizophrenic patients were separated into two groups according to whether they had detectable antibody (IgG or IgM) to T. gondii or not. The patients with detectable IgG or IgM antibody to T. gondii were the positive group (n=99), and the opposite was the negative group (n=501). There was no significant difference in age, education, duration of illness, or age of onset of schizophrenia between the two groups, and so was the age of the mothers of the two groups of patients ⑦ The rate of positive family history of mental disorders In the negative group was higher than that in the positive group (P < 0.01). The rates of IgG, IgM, IgG or IgM seropositive rate in the mothers of the positive group were higher than those in the mothers of the negative group (P < 0.01-0.05). The differences in total score, positive scale score, negative scale score, and general psychopathology scale score of PANSS between the seropositive and seronegative groups were not significant. ⑧ The following scores in the seropositive group were statistically higher than those in the seronegative group (P < 0.01): excitation, hostility, mannerisms and posturin, disturbance of volitio), poor impulse control and anger, difficulty in delaying gratification; and the score of suspiciousness in the seronegative group was lower than that of the seropositive group (P < 0.01). CONCLUSION: ① Toxoplasma infection is an important candidate etiological factor for schizophrenia. ② Toxoplasma infection has no significant correlation with schizophrenic patients' age, education, age of onset, course of disease and their mother's age. ③ The rate of positive family history of mental disorders in seronegative schizophrenic patients was higher than that in seropositive patients, and Toxoplasma infection was more common in mothers of schizophrenic patients with Toxoplasma infection. ④ Schizophrenic patients with Toxoplasma infection tend to be excited and agitated with disorganized behavior. For schizophrenic patients with disorganized behavior, attention should be paid to whether they have Toxoplasma infection.